Santen Pharmaceutical Co (JP:4536) has released an update.
Discover the Best Stocks and Maximize Your Portfolio:
- See what stocks are receiving strong buy ratings from top-rated analysts.
- Filter, analyze, and streamline your search for investment opportunities with TipRanks’ Stock Screener.
Santen Pharmaceutical Co., Ltd has reported a modest revenue increase of 3.3% for the three months ending June 30, 2024, compared to the same period last year. However, there has been a slight decrease in core net profit by 2.1%. The company has also announced a share repurchase program, which is expected to impact their earnings per share forecasts.
For further insights into JP:4536 stock, check out TipRanks’ Stock Analysis page.
